186 related articles for article (PubMed ID: 35507150)
1. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
Burke GW; Chandar J; Sageshima J; Ortigosa-Goggins M; Amarapurkar P; Mitrofanova A; Defreitas MJ; Katsoufis CP; Seeherunvong W; Centeno A; Pagan J; Mendez-Castaner LA; Mattiazzi AD; Kupin WL; Guerra G; Chen LJ; Morsi M; Figueiro JMG; Vianna R; Abitbol CL; Roth D; Fornoni A; Ruiz P; Ciancio G; Garin EH
Pediatr Nephrol; 2023 Jan; 38(1):145-159. PubMed ID: 35507150
[TBL] [Abstract][Full Text] [Related]
2. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
Delville M; Baye E; Durrbach A; Audard V; Kofman T; Braun L; Olagne J; Nguyen C; Deschênes G; Moulin B; Delahousse M; Kesler-Roussey G; Beaudreuil S; Martinez F; Rabant M; Grimbert P; Gallazzini M; Terzi F; Legendre C; Canaud G
J Am Soc Nephrol; 2016 Aug; 27(8):2520-7. PubMed ID: 26701979
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant.
Shah Y; Almeshari K; Aleid H; Broering D; Alahmadi I; Ali T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):178-180. PubMed ID: 30777550
[TBL] [Abstract][Full Text] [Related]
4. Abatacept in B7-1-positive proteinuric kidney disease.
Yu CC; Fornoni A; Weins A; Hakroush S; Maiguel D; Sageshima J; Chen L; Ciancio G; Faridi MH; Behr D; Campbell KN; Chang JM; Chen HC; Oh J; Faul C; Arnaout MA; Fiorina P; Gupta V; Greka A; Burke GW; Mundel P
N Engl J Med; 2013 Dec; 369(25):2416-23. PubMed ID: 24206430
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
Hansrivijit P; Puthenpura MM; Ghahramani N
Clin Nephrol; 2020 Sep; 94(3):117-126. PubMed ID: 32589135
[TBL] [Abstract][Full Text] [Related]
6. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
[TBL] [Abstract][Full Text] [Related]
7. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
Cleper R; Krause I; Bar Nathan N; Mor M; Dagan A; Weissman I; Frishberg Y; Rachamimov R; Mor E; Davidovits M
Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
[TBL] [Abstract][Full Text] [Related]
8. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
Garin EH; Reiser J; Cara-Fuentes G; Wei C; Matar D; Wang H; Alachkar N; Johnson RJ
Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
Mundel P
Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
[No Abstract] [Full Text] [Related]
10. Unsuccessful Treatment with Abatacept in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation.
Kristensen T; Ivarsen P; Povlsen JV
Case Rep Nephrol Dial; 2017; 7(1):1-5. PubMed ID: 28203563
[TBL] [Abstract][Full Text] [Related]
11. The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity.
Burke GW; Mitrofanova A; Fontanella A; Ciancio G; Roth D; Ruiz P; Abitbol C; Chandar J; Merscher S; Fornoni A
Front Immunol; 2023; 14():1201619. PubMed ID: 37564655
[TBL] [Abstract][Full Text] [Related]
12. Recurrent Focal Segmental Glomerulosclerosis and Abatacept: Case Report.
Alkandari O; Nampoory N; Nair P; Atta A; Zakaria Z; Mossad A; Yagan J; Al-Otaibi T
Exp Clin Transplant; 2016 Aug; 14(4):456-9. PubMed ID: 25432003
[TBL] [Abstract][Full Text] [Related]
13. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
[TBL] [Abstract][Full Text] [Related]
14. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS).
Canaud G; Dion D; Zuber J; Gubler MC; Sberro R; Thervet E; Snanoudj R; Charbit M; Salomon R; Martinez F; Legendre C; Noel LH; Niaudet P
Nephrol Dial Transplant; 2010 Apr; 25(4):1321-8. PubMed ID: 19773419
[TBL] [Abstract][Full Text] [Related]
15. A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis.
Soyaltın E; Demir BK; Alparslan C; Çamlar SA; Alaygut D; Yavaşcan Ö; Mutlubaş F
Turk J Pediatr; 2020; 62(4):663-667. PubMed ID: 32779421
[TBL] [Abstract][Full Text] [Related]
16. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
[TBL] [Abstract][Full Text] [Related]
17. The role of B7-1 in proteinuria of glomerular origin.
Novelli R; Benigni A; Remuzzi G
Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
[TBL] [Abstract][Full Text] [Related]
18. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
[TBL] [Abstract][Full Text] [Related]
20. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
